0

CGP 39551

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP127910321
CAS127910-32-1
Structure
MDL NumberMFCD00882474
Molecular Weight237.19
InChI KeyOKDOWCKDTWNRCB-GQCTYLIASA-N
Description≥98% (HPLC)
SolubilityH2O: 15 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

CGP 37849 and CGP 39551: Novel and Potent Competitive N-methyl-D-aspartate Receptor Antagonists With Oral Activity

G E Fagg, H R Olpe, M F Pozza, J Baud, M Steinmann, M Schmutz, C Portet, P Baumann, K Thedinga, H Bittiger

Br J Pharmacol. 1990 Apr;99(4):791-7.

PMID: 1972895

1

Effect of Developmental NMDAR Antagonism With CGP 39551 on Aspartame-Induced Hypothalamic and Adrenal Gene Expression

Kate S Collison, Angela Inglis, Sherin Shibin, Soad Saleh, Bernard Andres, Rosario Ubungen, Jennifer Thiam, Princess Mata, Futwan A Al-Mohanna

PLoS One. 2018 Mar 21;13(3):e0194416.

PMID: 29561882

1

Some Central Effects of CGP 37849 and CGP 39551, the Competitive NMDA Receptor Antagonists: Potential Antiparkinsonian Activity

J Maj, G Skuza, Z Rogóz

J Neural Transm Park Dis Dement Sect. 1993;6(1):53-62.

PMID: 8105798

1

The Competitive NMDA Receptor Antagonists CGP 37849 and CGP 39551 Are Potent, Orally-Active Anticonvulsants in Rodents

M Schmutz, C Portet, A Jeker, K Klebs, A Vassout, H Allgeier, R Heckendorn, G E Fagg, H R Olpe, H van Riezen

Naunyn Schmiedebergs Arch Pharmacol. 1990 Jul;342(1):61-6.

PMID: 1976233

1

The Effect of CGP 37849 and CGP 39551, Competitive NMDA Receptor Antagonists, in the Forced Swimming Test

J Maj, Z Rogóz, G Skuza, H Sowińska

Pol J Pharmacol Pharm. Jul-Aug 1992;44(4):337-46.

PMID: 1363131

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode